BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38378967)

  • 21. Cohesin occupancy and composition at enhancers and promoters are linked to DNA replication origin proximity in
    Pherson M; Misulovin Z; Gause M; Dorsett D
    Genome Res; 2019 Apr; 29(4):602-612. PubMed ID: 30796039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatics identification of miR-514b-5p promotes NSCLC progression and induces PI3K/AKT and p38 pathways by targeting small glutamine-rich tetratricopeptide repeat-containing protein beta.
    Shi L; Kan J; Zhuo L; Wang S; Chen S; Zhang B; Ke B
    FEBS J; 2023 Feb; 290(4):1134-1150. PubMed ID: 36180981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα.
    Yamamoto K; Tateishi K; Kudo Y; Sato T; Yamamoto S; Miyabayashi K; Matsusaka K; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Nakai Y; Isayama H; Ikenoue T; Kurokawa M; Fukayama M; Kokudo N; Omata M; Koike K
    Carcinogenesis; 2014 Nov; 35(11):2404-14. PubMed ID: 24947179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer.
    Wang H; Yu Z; Huo S; Chen Z; Ou Z; Mai J; Ding S; Zhang J
    Int J Biochem Cell Biol; 2018 Jan; 94():98-106. PubMed ID: 29208568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer.
    Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T
    Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KDM2B mediates the Wnt/β-catenin pathway through transcriptional activation of PKMYT1 via microRNA-let-7b-5p/EZH2 to affect the development of non-small cell lung cancer.
    Zhang X; Yin Z; Li C; Nie L; Chen K
    Exp Cell Res; 2022 Aug; 417(2):113208. PubMed ID: 35580699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.
    Xu W; Jiang K; Shen M; Chen Y; Huang HY
    Oncol Rep; 2016 Jan; 35(1):352-8. PubMed ID: 26498874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines.
    Wanna-Udom S; Terashima M; Suphakhong K; Ishimura A; Takino T; Suzuki T
    J Biol Chem; 2021; 296():100213. PubMed ID: 33779563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KDM6B Counteracts EZH2-Mediated Suppression of
    Wang W; Lim KG; Feng M; Bao Y; Lee PL; Cai Y; Chen Y; Zhang H; Marzese D; Hoon DSB; Yu Q
    Mol Cancer Ther; 2018 Sep; 17(9):1973-1983. PubMed ID: 29925528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer.
    Zang C; Nie FQ; Wang Q; Sun M; Li W; He J; Zhang M; Lu KH
    Oncotarget; 2016 Mar; 7(10):11696-707. PubMed ID: 26840083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancer.
    Shi B; Behrens C; Vaghani V; Riquelme EM; Rodriguez-Canales J; Kadara H; Lin H; Lee J; Liu H; Wistuba I; Simon G
    Cancer Med; 2019 Oct; 8(14):6383-6392. PubMed ID: 31456359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RAD21 is the core subunit of the cohesin complex involved in directing genome organization.
    Sun Y; Xu X; Zhao W; Zhang Y; Chen K; Li Y; Wang X; Zhang M; Xue B; Yu W; Hou Y; Wang C; Xie W; Li C; Kong D; Wang S; Sun Y
    Genome Biol; 2023 Jun; 24(1):155. PubMed ID: 37381036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-99b inhibits NSCLC cell invasion and migration by directly targeting NIPBL.
    Xu JX; Liu CM; Ma CP
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1890-1898. PubMed ID: 33660799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and significance of histone H3K27 demethylases in renal cell carcinoma.
    Shen Y; Guo X; Wang Y; Qiu W; Chang Y; Zhang A; Duan X
    BMC Cancer; 2012 Oct; 12():470. PubMed ID: 23057811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pluripotency factors and Polycomb Group proteins repress aryl hydrocarbon receptor expression in murine embryonic stem cells.
    Ko CI; Wang Q; Fan Y; Xia Y; Puga A
    Stem Cell Res; 2014 Jan; 12(1):296-308. PubMed ID: 24316986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone demethylase PHF8 promotes cell growth and metastasis of non-small-cell lung cancer through activating Wnt/β-catenin signaling pathway.
    Hu Y; Mu H; Yang Y
    Histol Histopathol; 2021 Aug; 36(8):869-877. PubMed ID: 34100557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation.
    Fujii S; Ito K; Ito Y; Ochiai A
    J Biol Chem; 2008 Jun; 283(25):17324-32. PubMed ID: 18430739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
    Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
    EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.